PERSPECTA

News from every angle

← Back to headlines

CRISPR Therapeutics Prices Upsized $550M Convertible Debt Offering

CRISPR Therapeutics has priced an upsized convertible debt offering totaling $550 million.

11 Mar, 11:07 — 11 Mar, 11:07
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed163d ago

CRISPR Therapeutics prices upsized $550M convertible debt offering

Read full article →

Related Stories

China Recalls 4.3 Million Vehicles, Including 2.98 Million Teslas, Over Safety Concerns

22m ago

TikTok Settles US Child Privacy Case for $400 Million

36m ago

Apple Cuts Jobs in Siri and Vision Pro Teams Amid AI Shift

41m ago

Moderna's Cancer Vaccine Breakthrough Boosts Biotech Hopes

1h ago